Trastuzumab Deruxtecan: Effects in Multiple Cancer Types Trastuzumab Deruxtecan: Effects in Multiple Cancer Types
Dr Maurie Markman discusses the concept of focusing on a particular molecular target and then potentially looking at the value of that drug across multiple tumor types.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 7, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
First-Line Nivolumab Plus Chemo Approved for Bladder Cancer
(MedPage Today) -- The FDA approved the PD-1 immune checkpoint inhibitor nivolumab (Opdivo) in combination with cisplatin and gemcitabine for the first-line treatment of adults with unresectable or metastatic urothelial carcinoma, the agency announced... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 7, 2024 Category: Hematology Source Type: news
First-Line Immunotherapy Alone Sufficient for Older NSCLC Patients, Study Suggests
(MedPage Today) -- Adding an immune checkpoint inhibitor (ICI) to chemotherapy for older patients with previously untreated advanced non-small cell lung cancer (NSCLC) provided no survival advantage compared with ICI therapy alone, according to... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 7, 2024 Category: Hematology Source Type: news
A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu
(MedPage Today) -- An interim analysis of the DREAMM-8 trial showed belantamab mafodotin (Blenrep) improved progression-free survival when combined with pomalidomide (Pomalyst) and dexamethasone as second-line treatment for patients with relapsed... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 7, 2024 Category: Hematology Source Type: news
GSK's Blood Cancer Drug Meets Main Goal in Late-stage Trial; Analysts Tout Comeback GSK's Blood Cancer Drug Meets Main Goal in Late-stage Trial; Analysts Tout Comeback
GSK said on Thursday a study showed its experimental drug Blenrep helped extend survival in patients with a type of blood cancer without symptoms worsening, marking a...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 7, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
FDA granted accelerated approval to belantamab mafodotin-blmf for multiple myeloma
Hematology / Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 7, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
S3 Episode 2: Improving Communication to Improve Lung Cancer Care S3 Episode 2: Improving Communication to Improve Lung Cancer Care
Drs Jacob Sands and Donald L. Rosenstein discuss the psychology of lung cancer and how to effectively communicate with patients about diagnosis, treatment, and expectations.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 7, 2024 Category: Consumer Health News Tags: Hematology-Oncology InDiscussion Source Type: news
S3 Episode 1: Improving Targeted Therapy Options for Lung Cancer Patients S3 Episode 1: Improving Targeted Therapy Options for Lung Cancer Patients
Drs Jacob Sands and Julia Rotow discuss the latest breakthroughs in lung cancer treatment, including targeted therapy options, toxicities, and diagnostic technology.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 7, 2024 Category: Consumer Health News Tags: Hematology-Oncology InDiscussion Source Type: news
FDA Okays Pfizer Antibody-Drug Conjugate for Pediatric ALL FDA Okays Pfizer Antibody-Drug Conjugate for Pediatric ALL
A complete remission rate of 42% led to the approval of inotuzumab ozogamicin for children.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 7, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Novel Regimens Yield High Response Rates for Older, Hodgkin Lymphoma Patients
(MedPage Today) -- Older patients with classical Hodgkin lymphoma unsuitable for conventional chemotherapy had high rates of durable responses with two brentuximab vedotin (BV; Adcetris) regimens, one that omitted chemotherapy, a small prospective... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 7, 2024 Category: Hematology Source Type: news
FDA OKs First Interchangeable Biosimilars for Denosumab
(MedPage Today) -- The FDA approved injectable Jubbonti and Wyost as the first interchangeable biosimilars to denosumab (Prolia, Xgeva), and for all the same indications, including the prevention of fractures in at-risk adults and skeletal-related... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 6, 2024 Category: Hematology Source Type: news
Change Healthcare Cyberattack:'Unsustainable' for Oncology Change Healthcare Cyberattack:'Unsustainable' for Oncology
Change Healthcare is focused on restoring its systems and minimizing disruptions to oncology practices after a cyberattack that occurred over 2 weeks ago.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 6, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Is Primary Tumor Resection Beneficial in Stage IV CRC? Is Primary Tumor Resection Beneficial in Stage IV CRC?
Primary tumor resection before chemotherapy does not prolong survival in patients with CRC and unresectable metastases, combined results from two trials indicate.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 6, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Cancer-causing Chemical Found in Clinique, Clearasil Acne Treatments, U.S. Lab Reports Cancer-causing Chemical Found in Clinique, Clearasil Acne Treatments, U.S. Lab Reports
High levels of cancer-causing chemical benzene were detected in some acne treatments from brands including Estee Lauder ' s Clinique, Target ' s Up& Up and Reckitt...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 6, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
World Bank, Gates, UN Pledge Close to $600m to End Cervical Cancer World Bank, Gates, UN Pledge Close to $600m to End Cervical Cancer
Global health donors pledged nearly $600 million towards eliminating cervical cancer on Tuesday, at the first global forum dedicated to fighting the disease.Reuters Health Information (Source: Medscape Pulmonary Medicine Headlines)
Source: Medscape Pulmonary Medicine Headlines - March 5, 2024 Category: Respiratory Medicine Tags: Hematology-Oncology Source Type: news
